- Home
- Equipment
- united kingdom
- spike protein
Refine by
Spike Protein Equipment Supplied In United Kingdom
6 equipment items found
Manufactured by:Immunodiagnostic Systems Holdings PLC based inBoldon Colliery, UNITED KINGDOM
The Spike Protein Inhibition Assay (SPIA) is a competitive immunoenzymatic colorimetric method used for research purposes only to detect neutralising antibodies against SARS-CoV-2 in human ...
Manufactured by:Yourgene Health based inManchester, UNITED KINGDOM
COVID-19 (also referred to as Coronavirus), is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Coronaviruses are enveloped RNA viruses. They are names as such due to the spike proteins projecting from their surface. SARS-CoV-2 is one of 7 total coronaviruses that commonly infect humans and is one of the 5 beta ...
by:Attomarker Ltd based inExeter, UNITED KINGDOM
The following single-chip panels are available for the Liscar 6 platform. Additional panels will be highlighted here as they come on stream so please check back regularly or get in touch so that we can notify you when new panels are released. ...
Manufactured by:AstraZeneca based inCambridge, UNITED KINGDOM
IVX-411 targets SARS-CoV-2, the coronavirus that causes COVID-19. Developed using cutting-edge structure-based design techniques at the Institute for Protein Design at the UW School of Medicine, IVX-411, our lead vaccine candidate for COVID-19, is a self-assembling protein nanoparticle that displays 60 copies of the SARS-CoV-2 spike (S) ...
Manufactured by:Biopanda Reagents Ltd based inBelfast, UNITED KINGDOM
The Biopanda COVID-19 RBD IgG Rapid Test Kit is a highly sensitive, qualitative lateral flow immunochromatographic assay for the detection of specific anti-Receptor Binding Domain (RBD) IgG antibodies to SARS-CoV-2 in human whole blood, serum or plasma samples. This test is intended for the detection of antibodies generated by vaccinations. This test kit is CE-marked for healthcare professional ...
Manufactured by:Treos Bio Limited based inLondon, UNITED KINGDOM
Using our proprietary computational vaccine design technology, we have developed a PolyPEPI preventive peptide vaccine against COVID-19 (SARS-CoV-2). The design of PolyPEPI-SCoV-2 exploits our knowledge on genetic heterogeneity of individuals and ethnicities. PolyPEPI-SCoV-2 vaccine can elicit broad and long-lasting immune responses in vaccinated subjects and can therefore protect people ...